AMCR vs PROK · P/E 18, rev $23.51B vs rev $376.0K
Amcor PLC (AMCR) versus ProKidney Corp. (PROK) — a side-by-side from cached financials, not a winner call.
Amcor PLC (AMCR) is a packaging & containers company listed on US.
ProKidney Corp. (PROK) is a biotechnology company listed on US.
Latest reported AMCR revenue for 2026-06-30 was $23.51B. Net income was $1.11B. Revenue was up 362.5% from 2025-06-30 to 2026-06-30. AMCR currently screens at market cap $22.52B and trailing P/E 17.6.
Latest reported PROK revenue for 2026-06-30 was $376.0K. Net income was -$48.5M. Revenue was up 66.4% from 2026-03-31 to 2026-06-30. PROK currently screens at market cap $543.7M.
AMCR currently screens at market cap $22.52B and trailing P/E 17.6. PROK currently screens at market cap $543.7M.
Not investment advice. Open the AMCR and PROK stock pages for the full models.
Not investment advice.